» Articles » PMID: 30019220

Laparoscopic Pyloroplasty Versus Endoscopic Per-oral Pyloromyotomy for the Treatment of Gastroparesis

Overview
Journal Surg Endosc
Publisher Springer
Date 2018 Jul 19
PMID 30019220
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gastroparesis is a debilitating functional disorder of the stomach characterized by delayed gastric emptying absent an obstructive etiology. Surgical or endoscopic disruption of the pylorus has been utilized to treat this disease, but there is little evidence comparing laparoscopic pyloroplasty (LP) with endoscopic per-oral pyloromyotomy (POP). Herein we describe our experience at our institution using a propensity-matched cohort study to compare outcomes between these procedures.

Methods: All patients who underwent LP for the treatment of gastroparesis from October 2014 through September 2017 at our institution were retrospectively reviewed. Propensity scoring was used to match these patients 1:1 to patients undergoing POP during this time period based on gender, age, and etiology of gastroparesis. Symptom scores using the Gastroparesis Cardinal Symptom Index (GCSI), scintigraphic gastric emptying studies (GES), and perioperative outcomes were compared between matched cohorts. Thirty patients underwent LP for gastroparesis during the study period which were matched 1:1 with patients undergoing POP. The etiology of gastroparesis was 63.3% idiopathic (n = 19), 20.0% post-surgical (n = 6), and 16.7% diabetic (n = 5) in both cohorts.

Results: Patients who underwent LP had a longer average length of stay (4.6 vs. 1.4 days, p = 0.003), operative time (99.3 vs. 33.9 min, p < 0.001), and estimated blood loss (12.9 vs. 0.4 mL, p < 0.001). There were more complications in the LP cohort (16.7 vs. 3.3%, p = 0.086), which included surgical site infection (6.7 vs. 0%, p = 0.153), pneumonia (6.7 vs. 0.0%, p = 0.153), and unplanned ICU admission (10.0 vs. 0.0%, p = 0.078). LP and POP both resulted in similar, significant improvements in both in GCSI scores and objective gastric emptying.

Conclusions: Per-oral endoscopic pyloromyotomy (POP) is safe and effective for the treatment of medical refractory gastroparesis. POP has less perioperative morbidity compared to LP with comparative functional outcomes.

Citing Articles

Outcomes after per oral pyloromyotomy based on gastroparesis etiology.

Khan S, Chambers K, Benson J, Boutros C, Wieland P, Chatha H Surg Endosc. 2024; 39(2):1114-1119.

PMID: 39702568 DOI: 10.1007/s00464-024-11468-5.


A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis.

Tan J, Wu H, Yang X, Yang Y, Zhang L, Wang P Surg Endosc. 2024; 38(12):7416-7425.

PMID: 39448403 PMC: 11614976. DOI: 10.1007/s00464-024-11184-0.


Applications of gastric peroral endoscopic myotomy in the treatment of upper gastrointestinal tract disease.

Chang S, Jin G, Sun H, Yang D, Tang T World J Gastrointest Surg. 2024; 16(3):658-669.

PMID: 38577089 PMC: 10989344. DOI: 10.4240/wjgs.v16.i3.658.


modelling of the effect of pyloric intervention procedures on gastric flow and emptying in a stomach with gastroparesis.

Kuhar S, Seo J, Pasricha P, Mittal R J R Soc Interface. 2024; 21(210):20230567.

PMID: 38263890 PMC: 10824103. DOI: 10.1098/rsif.2023.0567.


Precision Endoscopy in Peroral Myotomies for Motility Disorders of the Upper Gastrointestinal Tract: Current Insights and Prospective Avenues-A Comprehensive Review.

Mandarino F, Vespa E, Barchi A, Fasulo E, Sinagra E, Azzolini F Life (Basel). 2023; 13(11).

PMID: 38004283 PMC: 10672509. DOI: 10.3390/life13112143.


References
1.
Dacha S, Mekaroonkamol P, Li L, Shahnavaz N, Sakaria S, Keilin S . Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017; 86(2):282-289. DOI: 10.1016/j.gie.2017.01.031. View

2.
Ukleja A, Tandon K, Shah K, Alvarez A . Endoscopic botox injections in therapy of refractory gastroparesis. World J Gastrointest Endosc. 2015; 7(8):790-8. PMC: 4501969. DOI: 10.4253/wjge.v7.i8.790. View

3.
Kawai M, Peretta S, Burckhardt O, Dallemagne B, Marescaux J, Tanigawa N . Endoscopic pyloromyotomy: a new concept of minimally invasive surgery for pyloric stenosis. Endoscopy. 2012; 44(2):169-73. DOI: 10.1055/s-0031-1291475. View

4.
Shada A, Dunst C, Pescarus R, Speer E, Cassera M, Reavis K . Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc. 2015; 30(4):1326-32. DOI: 10.1007/s00464-015-4385-5. View

5.
Papasavas P, Ng J, Stone A, Ajayi O, Muddasani K, Tishler D . Gastric bypass surgery as treatment of recalcitrant gastroparesis. Surg Obes Relat Dis. 2014; 10(5):795-9. DOI: 10.1016/j.soard.2014.01.013. View